NVNO insider transaction filings
enVVeno Medical Corp — 26 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-14. Screen NVNO transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 1 Form 4 filing. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing by 1 insider — 11 shares, $123 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: sale of 11 shares @ $11.21 ($123) by Duhay Francis, filed 2026-09-14.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Duhay Francis — Director | 1 | — | 1 leg · 11 sh · $123 | — |
Recent Form 4 filings — enVVeno Medical Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-14 | 4 | Duhay Francis — Director | Sale (S): 11 @ $11.21 | EDGAR |
| 2026-06-12 | 4 | Duhay Francis — Director | Sale (S): 140 @ $10.30 | EDGAR |
| 2026-03-13 | 4 | Duhay Francis — Director | Sale (S): 140 @ $11.52 | EDGAR |
| 2025-12-18 | 4 | Alavi Hamed — Chief Technology Officer | Other (J): 50,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Glickman Marc H. — SVP & Chief Medical Officer | Other (J): 100,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | BERMAN ROBERT ANDREW — Chief Executive Officer, Director | Other (J): 200,000 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Duhay Francis — Director | Grant/award (A): 135,883 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Gray Robert — Director | Grant/award (A): 135,883 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Shrivastava Sanjay — Director | Grant/award (A): 135,883 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Jenusaitis Matthew — Director | Grant/award (A): 135,883 (derivative) @ $0 | EDGAR |
| 2025-12-12 | 4 | Duhay Francis — Director | Sale (S): 4,900 @ $0.36 | EDGAR |
| 2025-09-17 | 4 | Duhay Francis — Director | Sale (S): 4,900 @ $0.83 | EDGAR |
| 2025-05-20 | 4 | Bright Jennifer — Chief Financial Officer | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Duhay Francis — Director | Purchase (P): 81,433 @ $3.07 | EDGAR |
| 2025-01-02 | 4 | Gray Robert — Director | Purchase (P): 3,500 @ $2.94 | EDGAR |
| 2024-12-26 | 4 | Shrivastava Sanjay — Director | Purchase (P): 5,400 @ $2.90 | EDGAR |
| 2024-12-23 | 4 | Jenusaitis Matthew — Director | Purchase (P): 9,620 @ $2.53 | EDGAR |
| 2024-12-20 | 4 | Shrivastava Sanjay — Director | Grant/award (A): 19,752 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Gray Robert — Director | Grant/award (A): 19,752 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Glickman Marc H. — SVP & Chief Medical Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Alavi Hamed — Chief Technology Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Duhay Francis — Director | Grant/award (A): 19,752 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Jenusaitis Matthew — Director | Grant/award (A): 19,752 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | BERMAN ROBERT ANDREW — Chief Executive Officer, Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-12-19 | 4 | BERMAN ROBERT ANDREW — Chief Executive Officer, Director | Purchase (P): 12,000 @ $2.55 | EDGAR |
| 2024-03-15 | 4 | Alavi Hamed — Chief Technology Officer | Option exercise (M): 8,334 @ $3.59 · Sale (S): 8,334 @ $6.22 · Option exercise (M): 8,334 (derivative) @ $0 | EDGAR |
Recent 8-K events — enVVeno Medical Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-29 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-04 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-20 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-20 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-10 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-20 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NVNO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →